Related Experiment Video
Updated: Jul 14, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
CCN6 (WISP3) as a new regulator of the epithelial phenotype in breast cancer
Celina G Kleer1, Yanhong Zhang, Sofia D Merajver
1Department of Pathology, Division of Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Mich. 48109, USA. kleer@umich.edu
Abstract:
CCN6 (WISP3) is a cysteine-rich secreted protein that belongs to the CCN (Cyr61, CTGF, Nov) family of genes. We found that CCN6 mRNA is reduced in 80% of cases of the most lethal form of locally advanced breast cancer, inflammatory breast cancer. CCN6 contains four highly conserved motifs with sequence similarities to insulin-like growth factor binding proteins, von Willebrand type C, thrombospondin 1, and a carboxyl-terminal domain putatively involved in dimerization. CCN6 has tumor growth-, proliferation-, and invasion-inhibitory functions in breast cancer. Recently, by using a small infering RNA to downregulate CCN6 in immortalized human mammary epithelial cells, CCN6 was found to be essential to induce the process of epithelial-mesenchymal transition (EMT) with repression of E-cadherin gene expression and induction of a protein expression program characteristic of EMT. This review will focus on the current knowledge regarding the function of CCN6 in breast cancer with special emphasis on the emerging role of CCN6 as a regulator of the epithelial phenotype and E-cadherin expression in the breast.
Insights
CCN6 (WISP3) protein levels are reduced in inflammatory breast cancer, a lethal cancer type. Loss of CCN6 promotes epithelial-mesenchymal transition (EMT), crucial for cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- CCN6 (WISP3) is a secreted protein in the CCN gene family.
- It exhibits tumor growth, proliferation, and invasion inhibitory functions in breast cancer.
- CCN6 mRNA is reduced in 80% of locally advanced inflammatory breast cancer cases.
Purpose of the Study:
- To review the function of CCN6 in breast cancer.
- To emphasize CCN6's role in regulating epithelial phenotype and E-cadherin expression.
Main Methods:
- Review of existing literature on CCN6 function in breast cancer.
- Analysis of CCN6's role in epithelial-mesenchymal transition (EMT) induction.
- Investigation of CCN6's impact on E-cadherin gene expression.
Main Results:
- CCN6 deficiency is linked to reduced E-cadherin expression.
- Downregulation of CCN6 in mammary epithelial cells induces EMT.
- CCN6 acts as a regulator of the epithelial phenotype in breast cancer.
Conclusions:
- CCN6 plays a critical role in maintaining the epithelial phenotype in breast cancer.
- CCN6's function as a tumor suppressor is linked to its regulation of EMT and E-cadherin.
- Further research into CCN6 could offer new therapeutic strategies for inflammatory breast cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Non-Canonical Wnt Signaling Pathways
